Campbell & CO Investment Adviser LLC Kodiak Sciences Inc. Transaction History
Campbell & CO Investment Adviser LLC
- $1.26 Billion
- Q3 2025
A detailed history of Campbell & CO Investment Adviser LLC transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Campbell & CO Investment Adviser LLC holds 29,804 shares of KOD stock, worth $578,495. This represents 0.04% of its overall portfolio holdings.
Number of Shares
29,804Holding current value
$578,495% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding KOD
# of Institutions
108Shares Held
41.5MCall Options Held
73.7KPut Options Held
0-
Baker Bros. Advisors LP New York, NY17.3MShares$336 Million0.65% of portfolio
-
Black Rock Inc. New York, NY3.85MShares$74.7 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.06MShares$39.9 Million0.01% of portfolio
-
Acadian Asset Management LLC Boston, MA1.97MShares$38.2 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$37.9 Million0.0% of portfolio
About Kodiak Sciences Inc.
- Ticker KOD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,040,200
- Market Cap $1.01B
- Description
- Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...